Streetbeat News

Equity Actions

OVV

Ovintiv has received regulatory approvals to renew its share buy-back program, aligning with its capital allocation strategy to return at least 50% of post-dividend free cash flow to shareholders.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 9:23 pm

MLNK

MeridianLink has announced a proposed offering of 6 million shares of common stock by a selling shareholder. This move could impact the stock's supply and demand dynamics.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:32 pm

CUE

Cue BioPharma's shares are declining following the announcement of a proposed public offering.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:29 pm

CUE

Cue Biopharma has announced a proposed public offering, though the terms have not been disclosed. This move could impact the company's stock price as investors react to the news.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:28 pm

VINP

Vinci Partners Investments has approved a $15 million buyback program, as per an SEC filing. This move indicates confidence in the company's stock value and could positively impact its share price.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:25 pm

DHR

Danaher (NYSE:DHR) has seen a surge in options activity, with a significant portion of trades being bearish. Despite this, the stock price has risen by 3.38% to $276.93. Analysts have set a target price of $300, but recent options activity suggests mixed sentiment among investors.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 8:16 pm

AHT

Ashford Hospitality Trust plans a 1-for-10 reverse stock split to regain compliance with NYSE listing requirements.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:16 pm

DWAC

United Atlantic Ventures has significantly reduced its stake in Trump Media & Technology Group Corp., decreasing its ownership from 7.5 million shares to just 100 shares, effectively holding 0.0% of the company's outstanding stock.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:13 pm

NVNO

EnVVeno Medical's stock is declining following the announcement of a proposed public offering.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:10 pm

NVNO

enVVeno Medical Corporation has announced a proposed public offering, though the size of the offering has not been disclosed. This move could impact the company's stock price as investors react to the news.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:08 pm